Clinical Trial Update: Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating meropenem/amoxicillin-clavulanate and faropenem/amoxicillin-clavulanate for early bactericidal activity, safety, and tolerability in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Amoxycillin/CA (amoxicillin/clavulanate)
• Faropenem (faropenem)
• Meropenem (Meropenem)

Snippet

Sponsor: TASK Applied Science | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED